Glaucoma affects over 70 million people worldwide and over 12 million in the EU alone. Risk of glaucoma is higher for people suffering from diabetes, hypertension and the elderly as well as for specific ethnic backgrounds. It is a chronic condition with no permanent cure and is the second leading … [Read more...] about Glaucoma – Challenge and Solution
GlakoLens in TRT News
GlakoLens interview was published in TRT News. You can watch the interview below: … [Read more...] about GlakoLens in TRT News
Company Overview of GlakoLens
GlakoLens Raises €465k in Seed Funding
GlakoLens, an Istanbul, Turkey-based developer of contact lens based biosensor technologies, raised €465k in seed funding. ACT Venture Partners made the investment. The company will use the funds to focus on further refining, testing and then certifying the technology. Founded by the members of a … [Read more...] about GlakoLens Raises €465k in Seed Funding
GlakoLens in TIMETURK
